About the Company
Penumbra, Inc. is a medical device company headquartered in Alameda, California. The company was founded by Arani Bose and Adam Elsesser in 2004. It manufactures devices for interventional therapies to treat vascular conditions such as stroke and aneurysm.
Sector
Industrial Applications and Services
Industry
Surgical & Medical Instruments & Apparatus
Employees
2391
Exchange
NYSE
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $PEN News
Penumbra, Inc. to Present at the RBC Capital Markets Global Healthcare Conference
Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the RBC Capital Markets Global Healthcare Conference on Wednesday, May 15, 2024.
Here's Why You Should Invest in Penumbra (PEN) Stock for Now
Penumbra, Inc.'s PEN consistent revenue growth momentum is driven by the extraordinary patient outcomes with Lightning Flash, Lightning Bolt 7 and RED 72 with SENDit technology. The company’s ...
Penumbra, Inc. (PEN)
Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the RBC Capital Markets Global Healthcare Conference on Wednesday, May 15, 2024. Penumbra's (PEN ...
Penumbra Lightning Flash 2.0 CAVT System Cleared by FDA and Launched
Penumbra, Inc. announced the FDA clearance and launch of Lightning Flash 2.0, the company’s next-generation computer assist ...
PEN Quantitative Stock Analysis
Below is Validea's guru fundamental report for PENUMBRA INC (PEN). Of the 22 guru strategies we follow, PEN rates highest using our P/B Growth Investor model based on the published strategy of ...
Penumbra director sells $37,940 in company stock
Don W. Kassing, a director at Penumbra Inc (NYSE:PEN), has sold a portion of his holdings in the company, according to a recent filing with the Securities and Exchange Commission. The transaction ...
Penumbra, Inc.
Penumbra, Inc. engages in the design, development, manufacture, and marketing of innovative medical devices. It offers neurovascular thrombectomy and embolization and access technologies ...
Penumbra Inc.
No significant news for in the past two years. Key Stock Data P/E Ratio (TTM) The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing ...
Penumbra, Inc. (PEN)
Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the first quarter 2024 after market close on Tuesday, May 7, 2024 at 4:30 PM Eastern ...
Loading the latest forecasts...